Benchmark experiment for the cross section of the 100 Mo(p,2n) 99m Tc and 100 Mo(p,pn) 99 Mo reactions

Takács, S.; Ditrói, F.; Aikawa, Masanori; Haba, Hiromitsu; Otuka, Naohiko

doi:10.1016/j.nimb.2016.03.040

Cited by 4 publications

(1 citation statement)

References 20 publications

(4 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the 90’s, several researchers again started the investigation of the nuclear data for proton induced reactions for molybdenum radionuclides, most notably 100 Mo(p,2n) 99m Tc. The results renewed interest in the production of 99m Tc using cyclotrons and set the optimum production energy using protons in the range of 13.5–17 MeV, with a recommendation to avoid higher energies resulting in the production of inseparable impurities such as 98 Tc, 97 Tc and 96 Tc (Manenti et al, 2014 ; Qaim et al, 2014 ; Takacs et al, 2016 ).…”

Section: Developments In Radionuclide Productionmentioning

confidence: 99%

Production of novel diagnostic radionuclides in small medical cyclotrons

Synowiecki

Perk

Nijsen

2018

EJNMMI radiopharm. chem.

View full text Add to dashboard Cite

The global network of cyclotrons has expanded rapidly over the last decade. The bulk of its industrial potential is composed of small medical cyclotrons with a proton energy below 20 MeV for radionuclides production. This review focuses on the recent developments of novel medical radionuclides produced by cyclotrons in the energy range of 3 MeV to 20 MeV. The production of the following medical radionuclides will be described based on available literature sources: Tc-99 m, I-123, I-124, Zr-89, Cu-64, Ga-67, Ga-68, In-111, Y-86 and Sc-44. Remarkable developments in the production process have been observed in only some cases. More research is needed to make novel radionuclide cyclotron production available for the medical industry.

show abstract

Section: Developments In Radionuclide Productionmentioning

confidence: 99%